Related Experiment Video
Updated: Sep 5, 2025

12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.3K
Immunological Responses to Cancer Therapy.
1Department of Pulmonary Medicine, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
International Journal of Molecular Sciences
|July 9, 2022
Summary
Immunotherapy has rapidly advanced from an experimental cancer treatment to a standard clinical approach. This evolution highlights significant progress in harnessing the immune system to fight cancer.
Area of Science:
- Oncology
- Immunology
- Medical Science
Background:
- Immunotherapy has transitioned from an experimental concept to a mainstream cancer treatment over the past 20 years.
- Initially developed by laboratory scientists, it is now widely employed by clinicians for patient care.
Discussion:
- The rapid adoption of immunotherapy signifies a major breakthrough in cancer treatment paradigms.
- This shift underscores the growing understanding and application of immune system modulation in oncology.
Key Insights:
- The last two decades have witnessed a dramatic rise in the clinical application of cancer immunotherapy.
- Physicians now routinely utilize immunotherapy, reflecting its proven efficacy and integration into standard care.
Outlook:
- Continued research is expected to further refine and expand immunotherapy applications.
- The future of cancer treatment will likely involve increasingly sophisticated immune-based strategies.
Related Concept Videos
Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
Cytotoxic T Cells-mediated Immune Response
1.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.7K
Cancer Vaccines
503
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
503
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cell-mediated Immune Responses
71.5K
Overview
71.5K

